BRIEF-Daiichi Sankyo says entered into agreement with Servier Canada
June 27 (Reuters) - Daiichi Sankyo Co
* Daiichi Sankyo Co Ltd says has entered into an agreement with Servier Canada
* Agreement in which Servier Canada will market oral, once-daily anti-coagulant edoxaban in Canada, if approved by Canadian Health Authority
* Daiichi Sankyo Co Ltd says further financial details are not being disclosed
* Co will receive an upfront payment, payments based on regulatory and commercial milestones, as well as royalties on net product sales Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
© Thomson Reuters 2017 All rights reserved.